The Women’s Cancer Research Foundation (WCRF) annually publishes and funds numerous clinical studies on breast and gynecologic (ovarian, endometrial, and cervical) cancers. The WCRF’s oncology experts work tirelessly with the belief that each new clinical study has the potential to fundamentally improve the outcomes of patients diagnosed with breast and gynecologic cancers.
Long-term Pelvic Fracture and Overall Mortality Risk After Pelvic Cancer Radiation
Processed Foods and Cancer
Risk of Endometrial Polyps, Hyperplasia, Carcinoma, and Uterine Cancer After Tamoxifen Treatment
The Risks of Cancer in Older Women with BRCA Pathogenic Variants: How Far Have We Come?
Use of Straighteners and Other Hair Products and Incident Uterine Cancer
Cardiovascular Disease Diagnoses Among Older Women with Endometrial Cancer
Opportunistic Osteoporosis Screening in Gynecologic Cancer Survivors
Frequent Aspirin Use and Ovarian Cancer Risk
Three Icons of Stage and Screen Lost to Ovarian Cancer
New Treatment Brings Remission of Rectal Cancer in All Patients
Bisphosphonate Use and Ovarian Cancer Risk in Women Aged 50 Years and Older
Physical Activity and Gynecologic Cancer Outcomes
‘Drug factory’ Implants Eliminate Ovarian, Colorectal Cancer in Mice
Genetic Testing — A Game-Changer
Malnutrition As A Risk Factor for Post-operative Morbidity in Gynecologic Cancer
Risk of Cancer after Premenopausal Bilateral Oophorectomy
Prevention of Ovarian Cancer
Liquid Biopsy in Ovarian Cancer
Risk of Peritoneal Cancer After Risk-Reducing Bilateral Salpingo-Oophorectomy for Women
Daily Aspirin Offers No Benefit in Breast Cancer Survivors
